ZEB1 and mature T-cell and NK-cell non-Hodgkin lymphoma: The dose-dependent reduction of cell invasion was observed in PTCL cells treated with AT56 (Fig. 3j), which was accompanied by the decreased expression of zeb1 and vimentin (Fig. 3k).